Sup Report

Participant Number 20024
Endocrine Program
Supervisor Report
Cycle: 55, Survey: 4, Due Date: 5/04/2021
Report prepared by
RCPAQAP Chemical Pathology
Version 2. Report amended due to RCPAQAP error: Your performance summary may have been altered. This replaces Report ID
CPEN00550400020024-100SUP01.
Copyright
This material is copyright and may not be used in any form for advertising, sales promotion or publicity. The material may not be reproduced in whole or in part for any purpose whatsoever (including presentations at meetings and
conferences), without the prior written permission of the RCPA Quality Assurance Programs Pty Limited. Permission must be sought in writing from the Program but will not be unreasonably refused.
Confidentiality
RCPA Quality Assurance Programs Pty Limited keeps all participant details confidential. No information related to any of the participants will be divulged to a third party, unless required by legislation, without the express written
consent of the participant. General information may be discussed at meetings or presented as papers to journals.
RCPAQAP Phone +61 2 9045 6000 © 2021 RCPA Quality Assurance Programs Pty Ltd. All rights reserved Accredited for compliance with ISO/IEC 17043
Chemical Pathology ABN 32 003 520 072 Report Issued Wednesday, 28 April 2021 Accreditation Number: 14863
Suite 201, 8 Herbert

Street St Leonards
Report ID: CPEN00550400020024-100SUP02
NSW 2065
Printed Prepared by: Page 2
Apr 28 10:21:42 2021 RCPAQAP Chemical Pathology
CPEN00550400020024-100SUP02
2021 Endocrine Program Update

Version 2 Report
Due to an oversight, the expected value for Active B12 was omitted from version 1 of this report, which has
caused inappropriate assessment to occur. This has been corrected in this version. Participants who submit
results for Active B12 should re-review their performance in this re-issued report.
We apologise for the inconvenience.
INSULIN IN 2021 ENDOCRINE MATERIAL

We acknowledge the significant stability issues observed for Insulin in the 2021 Endocrine material.
Following a review of insulin results from recent Endocrine program surveys, and taking into consideration
customer feedback, RCPAQAP will distribute replacement samples to address this issue.
Customers who have reported for insulin at any time in 2021 will receive an Endocrine: Insulin
Supplementary kit in May. Twelve samples will be supplied, covering surveys 7 through 12 (samples 21-13 to
21-24). This new material should only be analysed for insulin.
Customers should disregard all previous survey assessments for insulin this year (samples 21-01 to 21-04).
No further survey reports for insulin will be issued for the remainder of cycle 55 (samples 21-05 to 21-12).
We apologise for this inconvenience. If you have any further enquiries, please log a request through myQAP
portal
Endocrine
CPEN00550400020024-100SUP02
Alpha-fetoprotein (kIU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
130 55
105 45
No. of Laboratories
No. of Laboratories
80 35
55 25
30 15
5 5
4 4
3 3
2 2
1 1
1 3 5 >8 <14 18 21 24 >28

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<26 33 38 42 >49 <37 48 54 60 >71

Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
15 30
13 25
No. of Laboratories
No. of Laboratories
11 20
9 15
7 10
5 5
4 4
3 3
2 2
1 1
<49 62 71 80 >93 <60 77 88 99 >116

Median Median
Endocrine
Page 5
Alpha-fetoprotein (kIU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
01P - Abbott ARCHITECT (i1000,i2000,i4000)
2143 82 3 34 52 19 70 19 3 D 01P 001 W
01W - Abbott Alinity i
261 89 3 37 54 20 70 20 3 D 01W 001
13P - Siemens Healthcare Diagnostics ADVIA Centaur/XP/XPT
158 90 3 27 36 22 74 25 5 D 13P 098 W
10101 22 4 D 13P 098 W
WESTERN AUSTRALIA GROUP Supervisor
Median 89 3 34 52 20 70 21 4
Mean 87 3 33 47 20 71 22 4
S.D. 4.4 0.0 5.1 9.9 1.5 2.3 2.6 1.0
No. 3 3 3 3 3 3 4 4
Out 0 0 0 0 0 0 0 0
All Results
Median 88 3 38 54 21 71 21 3
Mean 88 3 38 55 21 71 21 3
S.D. 6.4 0.5 2.7 3.9 1.8 5.3 1.8 0.5
No. 94 93 93 94 94 92 94 92
Out 0 1 3 2 1 3 0 2
* Results > 3 standard deviations from the Group Mean. Results outside the analytical performance specifications.
©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

ABN 32 003 520 072
CPEN00550400020024-100SUP02
CA-125 (kU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
8 14 20 >30 <23 33 39 45 >55

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<41 53 60 67 >79 <55 71 81 91 >107

Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<70 90 102 115 >135 <83 106 121 136 >159

Median Median
Endocrine
Page 7
CA-125 (kU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
2143 141 18 69 92 44 119 45 18 D 01P 001
261 149 19 75 100 46 120 44 19 D 01W 001
158 117 13 36 53 39 102 38 13 D 13P 098
10101 121 13 34 51 38 105 37 13 D 13P 098
Median 131 16 52 72 42 112 41 16
Mean 132 16 54 74 42 112 41 16
S.D. 15.4 3.2 21.5 25.6 3.9 9.3 4.1 3.2
No. 4 4 4 4 4 4 4 4
Out 0 0 0 0 0 0 0 0
All Results
Median 121 14 60 81 36 102 40 15
Mean 114 14 56 77 36 96 37 14
S.D. 23.4 3.0 12.6 17.1 7.7 20.6 7.6 3.1
No. 69 69 69 69 70 70 67 67
Out 0 0 0 0 0 0 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Carcino Embryonic Antigen (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<0.7 1.7 2.3 2.9 >3.9 <4.6 5.9 6.8 7.6 >8.9
Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<7.5 9.6 10.9 12.2 >14.3 <10.3 13.2 15.0 16.8 >19.7
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 15
9 13
No. of Laboratories
No. of Laboratories
8 11
7 9
6 7
5 5
4 4
3 3
2 2
1 1
<12.9 16.6 18.9 21.2 >24.9 <15.3 19.7 22.4 25.1 >29.5
Median Median
Endocrine
Page 9
Carcino Embryonic Antigen (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
2143 26.0 2.0 12.0 17.0 7.0 22.0 7.0 2.0 D 01P 001 W
261 29.3 2.7 13.8 18.7 7.9 23.2 7.6 2.5 D 01W 001 W
158 20.7 1.7 6.3 9.8 6.8 17.8 6.2 2.4 D 13P 098
10101 21.3 1.9 6.6 9.2 6.4 18.9 6.9 2.3 D 13P 098
Median 23.6 2.0 9.3 13.4 6.9 20.5 6.9 2.3
Mean 24.3 2.1 9.7 13.7 7.0 20.5 6.9 2.3
S.D. 4.08 0.43 3.80 4.88 0.63 2.54 0.57 0.22
No. 4 4 4 4 4 4 4 4
Out 0 0 0 0 0 0 0 0
All Results
Median 22.4 2.3 10.9 15.0 6.6 18.9 6.9 2.4
Mean 24.4 2.3 11.3 15.8 6.9 20.2 7.0 2.4
S.D. 3.68 0.29 1.78 2.46 0.89 3.14 0.83 0.26
No. 79 79 80 80 81 81 79 79
Out 0 0 0 0 0 0 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Ferritin (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
55 30
45 25
No. of Laboratories
No. of Laboratories
35 20
25 15
15 10
5 5
4 4
3 3
2 2
1 1
<6 13 17 21 >28 <122 172 202 233 >283

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
15 15
13 13
No. of Laboratories
No. of Laboratories
11 11
9 9
7 7
5 5
4 4
3 3
2 2
1 1
<225 316 372 428 >519 <327 460 541 622 >755
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
15 15
13 13
No. of Laboratories
No. of Laboratories
11 11
9 9
7 7
5 5
4 4
3 3
2 2
1 1
<421 592 696 800 >971 <510 717 843 969 >1176
Median Median
Endocrine
Page 11
Ferritin (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 1170 19 423 609 230 895 220 17 D 01P 001 W
1046 1082 18 436 642 240 891 229 17 D 01P 001 Z
1268 1145 18 430 639 248 962 220 17 D 01P 001 Z
261 1148 20 460 787 246 890 236 19 D 01W 001 W
10608 1018 21 463 717 246 950 253 18 D 01W 001 W
40 826 14 329 485 155 629 159 13 D 13P 098 V
1248 735 13 316 508 164 609 173 14 D 13P 098 V
2637 752 13 311 451 150 628 159 14 D 13P 098 V
13R - Siemens Healthcare Diagnostics ADVIA 1650/1800
158 777 13 203 311 176 645 176 11 T 13R 098 Z
10101 788 12 205 317 176 612 171 12 T 13R 098 Z
Median 922 16 376 558 203 768 198 16
Mean 944 16 358 547 203 771 200 15
S.D. 183.9 3.4 99.5 160.2 42.0 156.5 35.4 2.7
No. 10 10 10 10 10 10 10 10
Out 0 0 0 0 0 0 0 0
All Results
Median 843 17 372 541 198 696 207 17
Mean 882 16 363 539 195 704 195 16
S.D. 167.3 3.0 64.9 96.5 34.5 123.8 36.3 3.0
No. 136 135 141 141 147 147 146 146
Out 1 2 0 0 0 0 1 1

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Folate (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
85 85
70 70
No. of Laboratories
No. of Laboratories
55 55
40 40
25 25
10 10
8 8
6 6
4 4
2 2
<2.7 6.0 8.0 10.0 >13.3 <3.4 7.5 10.0 12.5 >16.6
Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<4.1 9.1 12.1 15.2 >20.2 <5.0 11.0 14.7 18.4 >24.4
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<5.9 12.9 17.2 21.5 >28.5 <6.8 15.0 20.0 25.0 >33.2
Median Median
Endocrine
Page 13
Folate (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 16.9 7.9 11.3 13.9 10.9 15.8 10.5 9.3 J 01P 001 W
1268 19.7 9.6 12.8 15.4 10.8 16.8 10.8 8.7 J 01P 001 W
261 18.8 8.6 14.3 16.3 11.8 17.0 12.9 10.4 J 01W 001 W
8.3 3.8 6.3 7.2 5.2 7.5 5.7 4.6
10608 18.8 8.8 11.6 14.2 10.4 15.2 10.5 9.1 J 01W 001 W
40 29.5 15.2 19.6 21.7 20.0 29.5 21.0 16.3 J 13P 098 W
158 31.4 17.9 12.1 13.9 16.8 27.3 20.7 16.8 J 13P 098 W
1248 37.4 16.1 20.9 24.4 20.0 29.3 19.4 18.9 J 13P 098 W
10101 30.7 16.1 12.5 14.2 16.0 26.8 15.4 14.9 J 13P 098 W
Median 24.6 12.4 12.6 14.8 13.9 21.9 14.1 12.6
Mean 25.4 12.5 14.4 16.8 14.6 22.2 15.1 13.0
S.D. 7.72 4.15 3.75 4.04 4.12 6.51 4.63 4.10
No. 8 8 8 8 8 8 8 8
Out 0 0 0 0 0 0 0 0
All Results
Median 20.0 7.9 12.1 14.7 10.1 17.2 9.9 8.1
Mean 21.9 8.8 13.4 16.4 11.3 19.3 11.6 9.3
S.D. 5.53 3.84 3.84 4.49 4.01 5.19 4.35 4.35
No. 165 167 172 174 174 175 174 174
Out 3 0 2 0 1 0 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Follicle Stimulating Hormone (IU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
85 85
70 70
No. of Laboratories
No. of Laboratories
55 55
40 40
25 25
10 10
8 8
6 6
4 4
2 2
<1.4 3.0 4.0 5.0 >6.6 <11.8 14.4 16.0 17.6 >20.2
Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
55 55
45 45
No. of Laboratories
No. of Laboratories
35 35
25 25
15 15
5 5
4 4
3 3
2 2
1 1
<20.4 24.9 27.7 30.5 >35.0 <29.0 35.5 39.4 43.3 >49.8
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
55 55
45 45
No. of Laboratories
No. of Laboratories
35 35
25 25
15 15
5 5
4 4
3 3
2 2
1 1
<37.2 45.5 50.5 55.5 >63.8 <46.0 56.2 62.5 68.8 >79.0
Median Median
Endocrine
Page 15
Follicle Stimulating Hormone (IU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 66.2 3.8 25.7 36.2 14.7 45.8 14.3 3.4 D 01P 001 Z
261 64.7 3.7 29.4 41.4 16.8 51.6 16.3 3.7 D 01W 001 Z
10608 66.1 3.7 29.1 40.8 15.2 48.7 15.9 3.6 D 01W 001 Z
09Y - Beckman Coulter UniCel DxI 600/800
452 74.7 4.7 29.1 46.1 17.8 55.1 19.4 4.4 D 09Y 016 W
1284 70.0 4.7 32.7 47.4 16.9 57.4 2.6 1.7 D 09Y 016 W
40 85.8 12.1 44.2 59.3 27.5 72.1 28.9 11.5 D 13P 098 X
158 88.7 12.2 36.6 46.7 28.7 76.4 26.6 10.3 D 13P 098
1248 82.7 10.7 42.4 56.8 29.6 71.9 28.6 11.4 D 13P 098 X
10101 82.0 11.6 31.5 44.6 28.0 77.2 28.2 11.3 D 13P 098 W
Median 74.7 4.7 31.5 46.1 17.8 57.4 19.4 4.4
Mean 75.7 7.5 33.4 46.6 21.7 61.8 20.1 6.8
S.D. 9.33 4.01 6.37 7.41 6.50 12.52 8.87 4.17
No. 9 9 9 9 9 9 9 9
Out 0 0 0 0 0 0 0 0
All Results
Median 62.5 4.0 27.7 39.4 16.0 50.5 16.0 4.0
Mean 67.5 5.2 31.0 43.9 18.6 55.5 18.4 5.0
S.D. 13.72 2.90 8.00 10.37 5.66 12.21 5.76 2.62
No. 179 180 186 186 184 185 184 181
Out 2 1 0 0 1 0 0 2

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Growth Hormone (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
55 30
45 25
No. of Laboratories
No. of Laboratories
35 20
25 15
15 10
5 5
4 4
3 3
2 2
1 1
0.4 1.4 >3.0 <1.6 3.2 4.2 5.2 >6.8

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<4.4 6.1 7.2 8.3 >10.0 <6.2 8.7 10.2 11.7 >14.2
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<7.7 10.9 12.8 14.7 >17.9 <9.1 12.8 15.1 17.4 >21.1
Median Median
Endocrine
Page 17
Growth Hormone (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
11L - Roche Diagnostics E170/cobas e601/e602(cobas 6000- IA)
261 14.4 0.3 6.9 9.9 3.9 12.3 4.2 0.3 I 11L 069 T
4.8 0.1 2.3 3.3 1.3 4.1 1.4 0.1
20B - Siemens Healthcare Diagnostics Immulite 2000/2000 XPi
190 18.9 0.6 8.7 11.4 4.5 15.6 4.8 0.6 D 20B 030 T
6.3 0.2 2.9 3.8 1.5 5.2 1.6 0.2
10459 16.8 0.6 9.3 13.2 4.2 13.8 3.9 0.6 D 20B 030 T
5.6 0.2 3.1 4.4 1.4 4.6 1.3 0.2
Median 16.8 0.6 8.7 11.4 4.2 13.8 4.2 0.6
Mean 16.7 0.5 8.3 11.5 4.2 13.9 4.3 0.5
S.D. 2.25 0.17 1.25 1.65 0.30 1.65 0.46 0.17
No. 3 3 3 3 3 3 3 3
Out 0 0 0 0 0 0 0 0
All Results
Median 15.1 0.4 7.2 10.2 4.1 12.8 4.2 0.3
Mean 16.1 0.4 7.3 10.6 4.0 13.2 4.1 0.4
S.D. 2.22 0.19 0.96 1.43 0.46 1.46 0.45 0.13
No. 46 47 47 47 50 50 50 47
Out 1 0 2 2 1 1 1 4

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Human Chorionic Gonadotrophin - Total (IU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
85 55
70 45
No. of Laboratories
No. of Laboratories
55 35
40 25
25 15
10 5
8 4
6 3
4 2
2 1
0.0 1.0 2.0 >3.6 <53.7 65.7 73.0 80.3 >92.3

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<106.3 130.0 144.4 158.8 >182.5 <159.0 194.4 216.0 237.6 >273.0
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<210.6 257.4 286.0 314.6 >361.4 <259.2 316.8 352.0 387.2 >444.8
Median Median
Endocrine
Page 19
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 335.7 < 1.2 137.3 207.6 67.8 264.3 69.4 < 1.2 D 01P 001 V
1046 352.4 < 1.2 142.6 212.8 68.1 267.9 72.4 < 1.2 D 01P 001 V
Median 344.0 1.1 140.0 210.2 67.9 266.1 70.9 1.1
Mean 344.0 1.1 140.0 210.2 67.9 266.1 70.9 1.1
S.D. 11.81 0.00 3.75 3.68 0.21 2.55 2.12 0.00
No. 2 2 2 2 2 2 2 2
Out 0 0 0 0 0 0 0 0
Median 338.0 1.1 139.5 205.5 68.1 267.0 70.8 1.1
Mean 338.7 1.1 139.6 205.8 69.9 270.0 71.3 1.2
S.D. 15.06 0.09 6.72 9.21 4.41 12.13 3.54 0.31
No. 21 19 22 22 22 22 22 22
Out 0 2 0 0 1 1 0 0

261 359.6 < 2.3 148.7 221.2 72.3 280.2 74.3 < 2.0 D 01W 001 V
10608 348.0 140.9 214.3 66.1 267.5 68.0 < 1.0 D 01W 001 V
Median 353.8 2.2 144.8 217.8 69.2 273.9 71.2 1.4
Mean 353.8 2.2 144.8 217.8 69.2 273.9 71.2 1.4
S.D. 8.20 0.00 5.52 4.88 4.38 8.98 4.45 0.71
No. 2 1 2 2 2 2 2 2
Out 0 0 0 0 0 0 0 0
Median 347.4 1.9 139.0 213.6 71.8 282.0 71.0 1.9
Mean 348.2 2.1 140.6 212.3 71.2 281.8 71.4 1.9
S.D. 10.98 0.42 6.38 6.97 3.75 10.38 3.13 0.49
No. 20 19 20 20 21 21 21 21
Out 1 0 1 1 0 0 0 0

452 342.3 0.3 144.3 215.9 76.9 306.0 77.7 < 2.0 D 09Y 016 V

ABN 32 003 520 072
Page 20
Human Chorionic Gonadotrophin - Total (IU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08 (Continued)
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
Median 342.3 0.3 144.3 215.9 76.9 306.0 77.7 1.9
Mean 342.3 0.3 144.3 215.9 76.9 306.0 77.7 1.9
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
Median 340.5 0.9 146.1 218.2 74.9 289.1 76.6 0.9
Mean 340.6 0.9 146.2 216.6 74.7 287.1 76.3 1.0
S.D. 18.66 0.49 4.57 9.92 3.21 11.49 3.40 0.58
No. 18 17 18 18 18 18 18 15
Out 0 0 0 0 0 0 0 0

40 377.3 5.4 152.7 224.4 82.2 303.2 83.1 4.8 D 13P 098 V
158 333.1 4.5 97.2 147.0 81.5 288.6 73.1 5.2 D 13P 098 V
1248 381.3 5.4 149.6 209.4 90.1 330.9 77.1 4.3 D 13P 098 V
10101 338.0 4.2 95.6 139.3 74.7 286.6 80.9 4.3 D 13P 098 V
Median 357.6 4.9 123.4 178.2 81.8 295.9 79.0 4.6
Mean 357.4 4.9 123.8 180.0 82.1 302.3 78.6 4.7
S.D. 25.39 0.62 31.64 43.13 6.30 20.44 4.40 0.44
No. 4 4 4 4 4 4 4 4
Out 0 0 0 0 0 0 0 0
Median 362.5 5.6 153.0 225.4 82.2 303.2 83.0 5.2
Mean 364.1 6.2 144.8 214.5 82.1 302.8 81.7 4.9
S.D. 17.97 2.52 24.25 37.02 3.94 14.67 4.68 0.84
No. 12 12 11 11 11 11 11 11
Out 0 0 0 0 0 0 0 0

190 563.0 < 1.0 211.0 298.0 112.0 367.0 115.0 < 1.0 D 20B 030 V
Median 563.0 0.9 211.0 298.0 112.0 367.0 115.0 0.9
Mean 563.0 0.9 211.0 298.0 112.0 367.0 115.0 0.9
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
Median 563.0 0.9 211.0 298.0 112.0 367.0 115.0 0.9
Mean 563.0 0.9 211.0 298.0 112.0 367.0 115.0 0.9
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0

ABN 32 003 520 072
Page 21
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
Median 350.2 2.2 143.5 213.6 75.8 287.6 75.7 1.9
Mean 373.1 2.8 142.0 209.0 79.2 296.2 79.1 2.6
S.D. 68.77 2.07 31.91 43.59 13.77 32.33 13.48 1.78
No. 10 9 10 10 10 10 10 10
Out 0 0 0 0 0 0 0 0
All Results
Median 352.0 1.0 144.4 216.0 73.0 286.0 73.0 1.0
Mean 352.7 1.0 144.6 216.2 73.5 286.1 73.8 1.0
S.D. 19.15 0.77 8.48 12.30 6.05 15.27 5.81 0.78
No. 183 162 180 181 185 186 189 166
Out 8 14 13 12 10 9 8 17

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Homocysteine (µmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<0.0 2.5 4.0 5.5 >8.0 <6.8 9.3 10.8 12.3 >14.8
Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
15 10
13 9
No. of Laboratories
No. of Laboratories
11 8
9 7
7 6
5 5
4 4
3 3
2 2
1 1
<12.5 15.3 17.0 18.7 >21.5 <16.9 20.7 23.0 25.3 >29.1
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
15 10
13 9
No. of Laboratories
No. of Laboratories
11 8
9 7
7 6
5 5
4 4
3 3
2 2
1 1
<22.3 27.3 30.3 33.3 >38.3 <26.5 32.4 36.0 39.6 >45.5
Median Median
Endocrine
Page 23
Homocysteine (µmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
2143 36.4 4.3 17.6 23.7 10.9 31.5 11.2 4.4 J 01P 001
261 36.1 3.9 17.1 23.0 10.8 29.9 10.9 4.2 J 01W 001
158 24.2 1.7 6.4 10.2 6.6 21.6 6.6 2.1 D 13P 098
2637 24.9 1.9 11.6 16.2 6.0 20.3 5.6 1.5 J 13P 098
10101 J 13P 098
Median 30.5 2.9 14.4 19.6 8.7 25.8 8.8 3.1
Mean 30.4 3.0 13.2 18.3 8.6 25.8 8.6 3.0
S.D. 6.76 1.34 5.27 6.36 2.64 5.69 2.89 1.47
No. 4 4 4 4 4 4 4 4
Out 0 0 0 0 0 0 0 0
All Results
Median 36.0 4.0 17.0 23.0 10.8 30.3 10.8 4.0
Mean 34.5 3.5 16.0 22.5 10.0 28.9 10.0 3.6
S.D. 5.34 1.01 2.73 3.35 2.03 4.35 1.98 1.00
No. 54 55 55 55 57 57 57 57
Out 1 0 1 1 0 0 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Insulin (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 15
25 13
No. of Laboratories
No. of Laboratories
20 11
15 9
10 7
5 5
4 4
3 3
2 2
1 1
0.5 1.1 >2.1 <0.7 1.7 2.3 2.9 >3.9

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 15
25 13
No. of Laboratories
No. of Laboratories
20 11
15 9
10 7
5 5
4 4
3 3
2 2
1 1
<4.3 5.5 6.3 7.1 >8.3 <8.9 11.4 13.0 14.6 >17.1
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
15 10
13 9
No. of Laboratories
No. of Laboratories
11 8
9 7
7 6
5 5
4 4
3 3
2 2
1 1
<15.3 19.7 22.3 25.0 >29.4 <23.8 30.6 34.8 38.9 >45.7
Median Median
Endocrine
Page 25
Insulin (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
1046 26.8 4.6 10.6 < 1.0 14.7 2.5 0.3 D 01P 001 U
261 37.7 < 1.0 8.4 18.3 2.6 33.0 3.5 < 1.0 I 11L 069 U
40 34.5 0.8 7.4 14.5 2.2 21.4 2.6 1.3 D 13P 098 U
158 33.8 1.0 3.0 7.1 2.5 24.3 2.9 1.5 D 13P 098 U
10101 D 13P 098 U
Median 34.2 0.9 6.0 12.6 2.3 22.8 2.8 1.1
Mean 33.2 0.9 5.8 12.6 2.0 23.4 2.9 1.0
S.D. 4.59 0.10 2.49 4.84 0.79 7.59 0.45 0.53
No. 4 3 4 4 4 4 4 4
Out 0 0 0 0 0 0 0 0
All Results
Median 34.8 0.6 6.3 13.0 2.2 22.3 2.5 0.5
Mean 35.4 0.7 6.0 12.9 2.2 22.8 2.4 0.6
S.D. 5.02 0.48 2.06 3.53 0.84 5.26 1.01 0.42
No. 74 71 79 79 77 80 71 62
Out 4 2 2 2 5 2 2 3

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Luteinising Hormone (IU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
110 55
90 45
No. of Laboratories
No. of Laboratories
70 35
50 25
30 15
10 5
8 4
6 3
4 2
2 1
0.9 2.4 3.9 >6.4 <12.7 17.9 21.0 24.1 >29.3

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<22.2 31.3 36.8 42.3 >51.4 <32.4 45.6 53.6 61.6 >74.8
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<42.4 59.6 70.1 80.7 >97.9 <52.3 73.5 86.4 99.4 >120.6
Median Median
Endocrine
Page 27
Luteinising Hormone (IU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 73.4 1.9 32.5 47.2 16.8 60.1 16.4 1.8 D 01P 001 V
261 73.5 1.8 32.8 48.0 16.1 58.5 16.4 1.9 D 01W 001
10608 76.6 1.9 31.8 45.6 15.0 52.7 15.3 1.7 D 01W 001 V
452 82.1 2.2 35.0 51.6 18.6 62.6 19.3 2.0 D 09Y 016 V
1284 76.6 1.8 32.3 49.6 19.6 71.1 1.0 0.0 D 09Y 016 V
40 97.1 2.4 39.0 54.5 20.2 74.7 22.2 2.6 D 13P 098 V
158 99.1 2.6 26.5 39.4 22.0 74.0 21.1 2.4 D 13P 098
1248 89.2 2.1 38.7 52.8 21.1 67.5 22.7 2.4 D 13P 098 V
10101 101.4 2.5 24.2 36.1 21.5 75.0 23.0 2.8 D 13P 098 W
Median 82.1 2.1 32.5 48.0 19.6 67.5 19.3 2.2
Mean 85.4 2.1 32.5 47.2 19.0 66.2 17.5 2.2
S.D. 11.44 0.31 4.90 6.09 2.52 8.12 6.85 0.40
No. 9 9 9 9 9 9 9 8
Out 0 0 0 0 0 0 0 0
All Results
Median 86.4 2.5 36.8 53.6 21.0 70.1 21.0 2.4
Mean 84.7 2.5 36.0 52.5 20.1 68.5 20.1 2.5
S.D. 9.55 0.67 4.53 5.99 3.21 7.73 3.02 0.69
No. 177 179 183 183 187 183 181 185
Out 7 4 6 6 1 5 7 1

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Prolactin (mIU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
55 105
45 85
No. of Laboratories
No. of Laboratories
35 65
25 45
15 25
5 5
4 4
3 3
2 2
1 1
<36 101 141 181 >246 <289 354 394 434 >499
Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<487 596 662 728 >837 <675 825 917 1009 >1159
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
55 55
45 45
No. of Laboratories
No. of Laboratories
35 35
25 25
15 15
5 5
4 4
3 3
2 2
1 1
<851 1040 1156 1271 >1460 <1015 1240 1378 1516 >1741
Median Median
Endocrine
Page 29
Prolactin (mIU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
2143 1466 128 642 911 392 1120 385 122 D 01P 001 V
261 1409 124 690 926 416 1164 397 130 D 01W 001 V
10608 1482 129 687 946 378 1111 385 117 D 01W 001 V
452 1194 134 563 793 390 1070 379 139 D 09Y 016 V
1284 1243 133 577 831 363 900 25 1 D 09Y 016 V
158 1122 132 387 558 366 1085 364 138 D 13P 098 V
2637 1286 142 639 833 376 1125 371 146 D 13P 098 V
10101 1290 142 355 526 348 1000 382 151 D 13P 098 V
Median 1288 132 608 832 377 1098 380 134
Mean 1312 133 568 790 379 1072 336 118
S.D. 129.8 6.4 129.7 162.4 20.9 84.5 126.0 48.6
No. 8 8 8 8 8 8 8 8
Out 0 0 0 0 0 0 0 0
All Results
Median 1378 138 662 917 394 1156 394 142
Mean 1467 148 697 975 427 1227 430 150
S.D. 273.5 24.4 126.7 178.4 76.8 225.7 77.8 26.2
No. 133 131 136 136 136 136 135 133
Out 2 3 1 1 2 2 2 4

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Sex Hormone Binding Globulin (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
80 55
65 45
No. of Laboratories
No. of Laboratories
50 35
35 25
20 15
5 5
4 4
3 3
2 2
1 1
0 6 12 >22 5 11 17 >27
Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
9 15 21 >31 <4 14 20 26 >36

Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<7 17 23 29 >39 <11 21 27 33 >43

Median Median
Endocrine
Page 31
Sex Hormone Binding Globulin (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
261 31 6 16 19 12 27 12 7 D 01W 001
158 27 7 11 14 11 23 11 6 D 20B 030
190 29 7 18 20 11 25 12 7 D 20B 030
10459 28 6 16 20 11 25 11 7 D 20B 030
Median 28 6 16 20 11 25 12 7
Mean 29 6 15 18 11 25 12 7
S.D. 1.7 0.6 3.0 2.9 0.5 1.6 0.6 0.5
No. 4 4 4 4 4 4 4 4
Out 0 0 0 0 0 0 0 0
All Results
Median 27 6 15 20 11 23 11 6
Mean 27 6 15 19 11 23 11 6
S.D. 1.7 0.9 1.3 1.5 1.1 1.9 0.8 0.7
No. 72 74 74 73 77 78 75 76
Out 3 0 2 3 1 0 3 1

ABN 32 003 520 072
CPEN00550400020024-100SUP02
TSH (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
185 80
150 65
No. of Laboratories
No. of Laboratories
115 50
80 35
45 20
10 5
8 4
6 3
4 2
2 1
0.02 0.12 >0.28 <2.11 3.58 4.47 5.36 >6.83

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
55 55
45 45
No. of Laboratories
No. of Laboratories
35 35
25 25
15 15
5 5
4 4
3 3
2 2
1 1
<4.03 6.82 8.53 10.24 >13.03 <5.95 10.08 12.60 15.12 >19.25
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
55 55
45 45
No. of Laboratories
No. of Laboratories
35 35
25 25
15 15
5 5
4 4
3 3
2 2
1 1
<7.83 13.25 16.56 19.87 >25.29 <9.64 16.32 20.40 24.48 >31.16
Median Median
Endocrine
Page 33
TSH (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 20.46 < 0.05 8.21 11.84 4.11 15.50 3.92 0.01 D 01P 001 W
1046 20.00 0.01 7.85 11.34 3.86 15.08 4.23 0.01 D 01P 001 W
1268 18.94 0.01 8.01 11.13 3.84 15.14 4.29 0.01 D 01P 001 W
Median 20.00 0.01 8.01 11.34 3.86 15.14 4.23 0.01
Mean 19.80 0.02 8.02 11.44 3.94 15.24 4.15 0.01
S.D. 0.779 0.017 0.180 0.365 0.150 0.227 0.199 0.000
No. 3 3 3 3 3 3 3 3
Out 0 0 0 0 0 0 0 0
Median 19.10 0.01 7.90 11.77 4.10 15.50 4.08 0.01
Mean 19.27 0.01 7.88 11.73 4.09 15.59 4.08 0.01
S.D. 0.841 0.003 0.403 0.531 0.167 0.555 0.184 0.000
No. 50 48 53 53 51 51 50 46
Out 2 1 0 0 1 1 2 3

261 21.51 0.01 8.92 12.67 4.38 16.70 4.46 0.01 D 01W 001 W
10608 19.33 0.01 8.26 12.51 4.06 15.56 3.78 0.01 D 01W 001 W
Median 20.42 0.01 8.59 12.59 4.22 16.13 4.12 0.01
Mean 20.42 0.01 8.59 12.59 4.22 16.13 4.12 0.01
S.D. 1.541 0.000 0.467 0.113 0.226 0.806 0.481 0.000
No. 2 2 2 2 2 2 2 2
Out 0 0 0 0 0 0 0 0
Median 19.48 0.01 8.03 12.00 4.09 15.56 4.10 0.01
Mean 19.53 0.01 8.08 12.06 4.14 15.60 4.13 0.01
S.D. 0.685 0.000 0.297 0.393 0.129 0.441 0.193 0.000
No. 20 19 21 21 22 22 20 20
Out 0 0 0 0 0 0 0 0

40 24.16 0.03 10.10 14.75 5.14 19.97 4.96 0.03 D 13P 098 X
158 22.80 0.03 6.38 9.78 5.28 21.02 5.16 0.02 D 13P 098 X
1248 24.69 0.03 9.69 14.34 5.55 21.56 5.01 0.03 D 13P 098 X
2637 23.34 0.03 9.71 14.18 5.39 21.26 5.09 0.03 D 13P 098 X
10101 26.74 0.03 6.27 9.96 5.26 21.00 5.31 0.03 D 13P 098 X

ABN 32 003 520 072
Page 34
TSH (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08 (Continued)

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
Median 24.16 0.03 9.69 14.18 5.28 21.02 5.09 0.03
Mean 24.35 0.03 8.43 12.60 5.32 20.96 5.11 0.03
S.D. 1.524 0.000 1.929 2.503 0.154 0.599 0.137 0.004
No. 5 5 5 5 5 5 5 5
Out 0 0 0 0 0 0 0 0
Median 23.58 0.03 9.42 14.11 5.02 19.29 5.00 0.03
Mean 24.07 0.03 9.09 13.72 4.99 19.47 4.98 0.03
S.D. 1.648 0.004 1.151 1.604 0.298 1.258 0.182 0.009
No. 16 15 16 16 17 17 16 15
Out 0 1 0 0 0 0 0 0

Median 22.15 0.03 8.24 12.18 4.76 18.33 4.71 0.01
Mean 22.20 0.02 8.34 12.25 4.69 18.28 4.62 0.02
S.D. 2.572 0.012 1.318 1.770 0.695 2.889 0.552 0.010
No. 10 10 10 10 10 10 10 10
Out 0 0 0 0 0 0 0 0
All Results
Median 20.40 0.02 8.53 12.60 4.45 16.56 4.49 0.02
Mean 20.67 0.02 8.58 12.74 4.45 16.85 4.47 0.02
S.D. 1.844 0.008 0.804 1.227 0.414 1.600 0.412 0.008
No. 208 207 214 215 216 215 213 202
Out 10 4 7 6 5 6 6 8

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Free Triiodthyronine (FT3) (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
60 60
50 50
No. of Laboratories
No. of Laboratories
40 40
30 30
20 20
10 10
8 8
6 6
4 4
2 2
<0.4 1.5 2.2 2.9 >4.0 <2.3 3.8 4.8 5.8 >7.3
Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<3.6 6.1 7.6 9.1 >11.6 <4.7 8.0 10.0 12.0 >15.3
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<5.7 9.7 12.1 14.5 >18.5 <6.9 11.6 14.5 17.4 >22.1
Median Median
Endocrine
Page 36
Free Triiodthyronine (FT3) (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 J 01P 001
1268 18.9 1.3 7.6 10.6 4.6 14.7 5.0 1.6 J 01P 001
Median 18.9 1.3 7.6 10.6 4.6 14.7 5.0 1.6
Mean 18.9 1.3 7.6 10.6 4.6 14.7 5.0 1.6
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
Median 19.1 2.2 7.7 11.0 4.8 14.4 4.9 2.2
Mean 19.0 2.1 7.7 11.0 4.9 14.3 4.9 2.2
S.D. 1.49 0.38 0.29 0.50 0.30 0.76 0.42 0.37
No. 47 47 48 48 44 45 46 46
Out 0 0 0 0 2 1 0 0

261 21.3 1.8 8.3 11.0 4.7 14.5 4.6 < 1.5 J 01W 001
10459 19.5 1.4 8.4 12.4 4.3 14.3 4.7 1.6 J 01W 001
Median 20.4 1.6 8.4 11.7 4.5 14.4 4.6 1.5
Mean 20.4 1.6 8.4 11.7 4.5 14.4 4.6 1.5
S.D. 1.27 0.28 0.07 0.99 0.28 0.14 0.07 0.14
No. 2 2 2 2 2 2 2 2
Out 0 0 0 0 0 0 0 0
Median 19.1 2.0 7.8 11.3 4.7 15.3 4.6 1.8
Mean 19.8 2.0 7.9 11.4 4.7 15.4 4.7 1.8
S.D. 1.71 0.27 0.53 0.60 0.31 1.22 0.29 0.35
No. 11 11 12 12 13 13 12 12
Out 0 0 0 0 0 0 0 0

40 11.8 4.4 8.8 10.2 7.8 11.1 7.8 4.8 J 13P 098
158 12.1 4.6 8.2 9.7 6.4 11.1 7.1 4.2 J 13P 098
1248 11.7 4.4 9.2 10.0 7.4 10.9 7.6 4.4 J 13P 098
2637 11.3 4.8 9.9 11.1 7.8 10.8 7.7 4.3 J 13P 098
10101 11.3 4.0 7.8 9.4 7.1 11.9 7.1 4.0 J 13P 098

ABN 32 003 520 072
Page 37
Free Triiodthyronine (FT3) (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08 (Continued)
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
Median 11.7 4.4 8.8 10.0 7.4 11.1 7.6 4.3
Mean 11.6 4.4 8.8 10.1 7.3 11.2 7.5 4.3
S.D. 0.34 0.30 0.83 0.65 0.58 0.43 0.34 0.30
No. 5 5 5 5 5 5 5 5
Out 0 0 0 0 0 0 0 0
Median 11.6 4.5 9.2 10.1 7.4 11.1 7.6 4.4
Mean 11.6 4.5 9.1 10.2 7.4 11.1 7.6 4.4
S.D. 0.32 0.30 0.57 0.69 0.49 0.49 0.30 0.25
No. 15 15 15 15 15 15 14 12
Out 0 0 0 0 0 0 0 1

Median 12.0 4.2 8.4 10.4 6.8 11.5 7.1 4.1
Mean 14.7 3.3 8.5 10.6 6.3 12.4 6.4 3.3
S.D. 4.33 1.54 0.75 0.96 1.50 1.76 1.42 1.47
No. 8 8 8 8 8 8 8 8
Out 0 0 0 0 0 0 0 0
All Results
Median 14.5 2.3 7.6 10.0 4.8 12.1 4.8 2.2
Mean 15.0 2.6 7.6 10.0 5.3 12.3 5.3 2.6
S.D. 3.48 0.99 1.11 1.32 1.25 1.99 1.24 0.94
No. 170 170 172 173 173 172 169 167
Out 0 0 1 0 0 1 1 2

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Free Thyroxine (FT4) (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
80 55
65 45
No. of Laboratories
No. of Laboratories
50 35
35 25
20 15
5 5
4 4
3 3
2 2
1 1
<2.6 5.1 6.6 8.1 >10.6 <12.2 15.7 17.8 19.9 >23.4
Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 80
25 65
No. of Laboratories
No. of Laboratories
20 50
15 35
10 20
5 5
4 4
3 3
2 2
1 1
<15.8 20.4 23.1 25.9 >30.5 <18.6 23.9 27.2 30.4 >35.7
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
105 105
85 85
No. of Laboratories
No. of Laboratories
65 65
45 45
25 25
5 5
4 4
3 3
2 2
1 1
<20.6 26.6 30.2 33.8 >39.8 <22.6 29.1 33.1 37.1 >43.6
Median Median
Endocrine
Page 39
Free Thyroxine (FT4) (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 31.6 6.0 19.1 25.6 11.7 27.0 12.5 6.0 J 01P 001
1046 29.1 < 5.2 18.4 24.0 12.5 27.9 13.6 6.3 J 01P 001
1268 29.1 6.1 19.9 27.7 11.3 28.9 12.1 6.0 J 01P 001
Median 29.1 6.0 19.1 25.6 11.7 27.9 12.5 6.0
Mean 29.9 5.7 19.1 25.8 11.8 27.9 12.7 6.1
S.D. 1.44 0.55 0.75 1.86 0.61 0.95 0.78 0.17
No. 3 3 3 3 3 3 3 3
Out 0 0 0 0 0 0 0 0
Median 30.6 6.1 17.8 23.1 12.4 27.3 12.4 6.1
Mean 30.7 6.1 17.8 23.2 12.4 27.3 12.5 6.2
S.D. 1.47 0.51 0.84 1.05 0.45 1.12 0.45 0.42
No. 52 51 54 53 51 52 53 53
Out 1 2 0 1 2 1 0 0

261 28.8 5.7 18.0 23.2 12.3 26.4 11.6 < 5.0 J 01W 001
10608 28.9 5.1 17.5 22.0 12.9 26.0 13.0 6.4 J 01W 001
Median 28.8 5.4 17.8 22.6 12.6 26.2 12.3 5.7
Mean 28.8 5.4 17.8 22.6 12.6 26.2 12.3 5.7
S.D. 0.07 0.42 0.35 0.85 0.42 0.28 0.99 1.06
No. 2 2 2 2 2 2 2 2
Out 0 0 0 0 0 0 0 0
Median 29.0 5.6 17.2 21.8 11.8 25.0 11.6 5.5
Mean 28.8 5.6 17.2 21.9 12.0 25.1 11.9 5.6
S.D. 1.40 0.33 0.72 1.13 0.53 1.03 0.49 0.40
No. 20 20 20 20 21 21 19 19
Out 0 0 0 0 0 0 0 0

40 28.8 8.2 23.0 27.2 18.9 28.7 19.3 9.6 J 13P 098
158 33.7 10.3 28.5 32.1 18.6 26.5 20.8 9.8 J 13P 098
1248 34.0 9.1 23.3 26.3 19.3 27.8 19.6 11.0 J 13P 098
2637 30.7 11.6 26.4 27.9 19.1 27.7 21.4 11.2 J 13P 098
10101 35.4 12.1 25.4 29.9 18.0 26.8 19.0 9.8 J 13P 098

ABN 32 003 520 072
Page 40
Free Thyroxine (FT4) (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08 (Continued)
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
Median 33.7 10.3 25.4 27.9 18.9 27.7 19.6 9.8
Mean 32.5 10.3 25.3 28.7 18.8 27.5 20.0 10.3
S.D. 2.69 1.64 2.28 2.33 0.51 0.87 1.03 0.76
No. 5 5 5 5 5 5 5 5
Out 0 0 0 0 0 0 0 0
Median 32.5 10.0 24.0 27.4 19.3 29.4 19.1 9.8
Mean 32.2 10.1 24.3 27.8 19.6 29.4 19.2 9.7
S.D. 2.04 1.24 2.23 1.77 1.47 2.47 1.42 1.26
No. 16 16 16 16 16 16 16 14
Out 0 0 0 0 1 1 0 1

Median 29.9 7.1 21.5 26.8 15.4 27.4 16.3 8.0
Mean 31.0 7.9 22.0 26.6 15.5 27.4 16.3 8.1
S.D. 2.53 2.71 3.91 3.07 3.54 0.98 4.02 2.39
No. 10 10 10 10 10 10 10 10
Out 0 0 0 0 0 0 0 0
All Results
Median 33.1 6.6 23.1 27.2 17.7 30.2 18.0 6.6
Mean 39.5 6.7 23.8 30.1 16.6 35.0 16.6 6.7
S.D. 9.99 1.01 5.46 7.03 3.60 8.34 3.53 0.87
No. 215 204 218 218 217 217 214 199
Out 1 12 0 0 1 1 1 15

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Vitamin B12 (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 55
25 45
No. of Laboratories
No. of Laboratories
20 35
15 25
10 15
5 5
4 4
3 3
2 2
1 1
<39 68 86 104 >133 <94 132 156 179 >217

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<134 188 221 254 >308 <175 246 290 334 >405
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<220 309 364 419 >508 <257 362 426 489 >594
Median Median
Endocrine
Page 42
Vitamin B12 (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 366 69 234 300 151 359 168 80 J 01P 001 @
2143 407 92 240 298 194 424 37 15 J 01P 001
261 487 89 233 336 161 425 176 107 J 01W 001
10608 441 111 248 338 176 367 163 103 J 01W
40 484 69 213 285 142 374 143 70 J 13P 098 A
158 376 76 105 131 157 324 127 89 J 13P 098
1248 472 72 203 257 133 373 152 70 J 13P 098 A
10101 358 80 95 164 117 330 127 84 J 13P 098 A
Median 424 78 223 292 154 370 148 82
Mean 424 82 196 264 154 372 137 77
S.D. 54.1 14.5 61.3 76.8 24.2 37.4 44.1 28.6
No. 8 8 8 8 8 8 8 8
Out 0 0 0 0 0 0 0 0
All Results
Median 426 86 221 290 156 364 156 86
Mean 420 82 216 285 151 357 151 85
S.D. 45.3 20.7 24.9 31.2 21.7 38.0 22.6 20.2
No. 164 161 166 167 167 165 168 167
Out 0 2 4 3 3 5 2 3

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Prostate Specific Antigen - Total (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
220 30
180 25
No. of Laboratories
No. of Laboratories
140 20
100 15
60 10
20 5
16 4
12 3
8 2
4 1
0.05 0.45 >1.10 <3.98 4.65 5.05 5.45 >6.12

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
15 15
13 13
No. of Laboratories
No. of Laboratories
11 11
9 9
7 7
5 5
4 4
3 3
2 2
1 1
<7.93 9.25 10.05 10.85 >12.17 <11.84 13.81 15.01 16.21 >18.18
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
15 15
13 13
No. of Laboratories
No. of Laboratories
11 11
9 9
7 7
5 5
4 4
3 3
2 2
1 1
<15.59 18.18 19.76 21.34 >23.93 <19.63 22.89 24.88 26.87 >30.13
Median Median
Endocrine
Page 44
Prostate Specific Antigen - Total (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
1046 24.57 0.04 9.58 14.16 5.11 20.03 4.74 0.04 D 01P 001 V
2143 21.52 0.04 10.71 14.75 4.98 17.99 4.16 0.04 D 01P 001 V
261 25.99 0.04 11.12 15.17 5.59 19.57 5.55 0.04 D 01W 001 V
2637 24.73 0.05 10.83 14.67 5.04 20.06 D 01W 001 V
10459 23.46 0.04 9.60 14.00 4.65 17.25 4.91 0.04 D 01W 001 V
40 26.90 0.06 10.44 13.92 4.89 19.61 4.83 0.07 D 13P 098 V
158 24.47 0.07 10.13 14.69 4.50 18.75 5.00 0.07 D 13P 098 V
1248 24.77 0.08 9.56 14.33 4.77 19.42 4.77 0.08 D 13P 098 V
10101 24.32 0.09 10.67 14.81 5.14 20.10 4.74 0.05 D 13P 098 V
Median 24.57 0.05 10.44 14.67 4.98 19.57 4.80 0.05
Mean 24.53 0.06 10.29 14.50 4.96 19.20 4.84 0.05
S.D. 1.504 0.019 0.598 0.419 0.318 1.004 0.382 0.017
No. 9 9 9 9 9 9 8 8
Out 0 0 0 0 0 0 0 0
All Results
Median 24.88 0.05 10.05 15.01 5.10 19.76 5.00 0.05
Mean 24.94 0.05 10.10 15.06 5.10 19.88 5.05 0.05
S.D. 2.108 0.014 0.765 1.202 0.413 1.563 0.371 0.013
No. 115 113 117 115 115 113 112 109
Out 0 2 0 2 0 2 2 3

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Prostate Specific Antigen - Free (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
55 35
45 30
No. of Laboratories
No. of Laboratories
35 25
25 20
15 15
5 10
4 8
3 6
2 4
1 2
0.01 0.21 >0.54 <1.04 1.46 1.72 1.98 >2.40

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
15 10
13 9
No. of Laboratories
No. of Laboratories
11 8
9 7
7 6
5 5
4 4
3 3
2 2
1 1
<2.11 2.96 3.49 4.01 >4.86 <3.04 4.27 5.03 5.78 >7.01
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<4.11 5.78 6.81 7.83 >9.50 <5.20 7.31 8.60 9.88 >11.99
Median Median
Endocrine
Page 46
Prostate Specific Antigen - Free (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
2143 8.70 < 0.01 3.60 5.00 1.80 6.90 1.70 0.00 D 01P 001 W
261 9.21 < 0.00 3.60 5.26 1.74 6.88 1.73 0.00 D 01W 001 V
10459 9.00 3.70 5.60 1.90 7.60 1.70 0.00 D 01W 001 V
40 7.73 0.01 3.37 4.85 1.74 6.80 1.62 0.00 D 13P 098 X
158 7.88 < 0.01 3.31 4.79 1.63 6.28 1.73 0.00 D 13P 098 V
2637 8.51 0.01 3.27 4.82 1.70 6.43 1.63 0.00 D 13P 098 X
10101 8.29 < 0.01 3.41 4.69 1.65 6.25 D 13P 098 V
Median 8.51 0.01 3.41 4.85 1.74 6.80 1.70
Mean 8.47 0.01 3.47 5.00 1.74 6.73 1.69
S.D. 0.549 0.000 0.166 0.322 0.092 0.472 0.048
No. 7 2 7 7 7 7 6
Out 0 0 0 0 0 0 0
All Results
Median 8.60 0.01 3.49 5.03 1.74 6.81 1.71 0.01
Mean 8.58 0.01 3.48 5.10 1.76 6.85 1.73 0.01
S.D. 0.907 0.004 0.335 0.525 0.199 0.654 0.213 0.006
No. 53 24 53 52 54 54 53 16
Out 1 1 1 2 0 0 0 1

ABN 32 003 520 072
CPEN00550400020024-100SUP02
ACE Activity (U/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
15 10
13 9
No. of Laboratories
No. of Laboratories
11 8
9 7
7 6
5 5
4 4
3 3
2 2
1 1
<11 16 19 22 >27 <32 40 44 48 >56

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<48 58 65 72 >82 <61 75 83 91 >105

Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<78 95 106 117 >134 <84 103 114 125 >144

Median Median
Endocrine
Page 48
ACE Activity (U/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
21M - Roche Diagnostics Hitachi cobas c501/c502
190 120 21 71 81 50 107 53 29 F 21M 304
Median 120 21 71 81 50 107 53 29
Mean 120 21 71 81 50 107 53 29
S.D. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
All Results
Median 114 19 65 83 43 106 44 19
Mean 116 19 67 86 43 107 44 19
S.D. 7.4 3.4 6.7 9.4 5.4 8.7 4.2 3.7
No. 24 26 29 30 30 30 27 27
Out 3 1 1 0 0 0 1 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Anti-Mullerian Hormone (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 15
25 13
No. of Laboratories
No. of Laboratories
20 11
15 9
10 7
5 5
4 4
3 3
2 2
1 1
<0.4 2.0 3.0 4.0 >5.6 <9.4 13.3 15.6 17.9 >21.8
Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<16.9 23.8 28.0 32.2 >39.1 <24.2 34.0 40.0 46.0 >55.8
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<32.2 45.3 53.3 61.3 >74.4 <40.4 56.9 66.9 76.9 >93.4
Median Median
Endocrine
Page 50
Anti-Mullerian Hormone (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
158 64.7 3.0 28.1 40.3 16.3 55.3 17.8 3.3 I 11L 069
261 64.7 3.0 27.8 38.8 14.7 49.5 15.5 2.9 I 11L 069
11V - Roche Diagnostics cobas e801
10459 62.9 2.9 26.4 37.7 15.8 52.2 16.2 3.0 I 11V 021
Median 64.7 3.0 27.8 38.8 15.8 52.2 16.2 3.0
Mean 64.1 3.0 27.4 38.9 15.6 52.3 16.5 3.1
S.D. 1.04 0.06 0.91 1.31 0.82 2.90 1.18 0.21
No. 3 3 3 3 3 3 3 3
Out 0 0 0 0 0 0 0 0
All Results
Median 66.9 3.0 28.0 40.0 15.8 53.3 15.5 3.0
Mean 66.0 3.0 27.9 40.2 15.7 52.9 15.7 3.0
S.D. 3.98 0.18 1.21 2.54 0.99 3.67 0.84 0.19
No. 31 31 31 33 33 33 33 32
Out 1 1 2 0 0 0 1 2

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Aldosterone (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<17 56 80 104 >143 <215 303 356 409 >497

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<375 527 620 713 >865 <542 762 896 1030 >1250
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<665 935 1100 1265 >1535 <820 1153 1357 1561 >1894
Median Median
Endocrine
Page 52
Aldosterone (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
99B - DiaSorin Liaison XL
261 1520 138 801 989 354 1090 344 75 D 99B 135
10459 1300 100 559 722 349 1040 337 72 D 99B 135
Median 1519 100 663 850 355 1124 362 64
Mean 1446 94 674 854 356 1118 368 63
S.D. 126.7 46.8 121.4 133.5 6.7 65.2 34.3 12.7
No. 3 3 3 3 4 4 4 4
Out 0 0 0 0 0 0 0 0
All Results
Median 1357 96 620 896 359 1100 344 75
Mean 1373 91 631 879 358 1116 346 79
S.D. 159.3 29.2 69.1 75.7 63.4 74.1 54.6 28.2
No. 30 30 31 31 33 31 33 33
Out 0 0 0 0 0 2 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Androstenedione (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 15
25 13
No. of Laboratories
No. of Laboratories
20 11
15 9
10 7
5 5
4 4
3 3
2 2
1 1
1.3 2.8 4.3 >6.8 <3.0 5.5 7.0 8.5 >11.0

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<6.4 9.0 10.6 12.2 >14.8 <9.1 12.8 15.0 17.2 >20.9
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<11.3 15.9 18.8 21.6 >26.2 <13.7 19.3 22.7 26.1 >31.7
Median Median
Endocrine
Page 54
Androstenedione (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
261 > 35.0 4.0 23.2 27.9 11.0 29.6 10.7 3.0 D 20B 030
22D - Sample Preparation Liquid-Liquid Extraction (LLE)
2438 21.1 2.3 10.6 14.6 6.6 17.5 7.0 2.8 T 22D 000
10459 22.4 2.5 10.4 13.9 7.2 15.7 5.6 2.7 T 22D 000
Median 22.4 2.5 10.6 14.6 7.2 17.5 7.0 2.8
Mean 26.2 2.9 14.7 18.8 8.3 20.9 7.8 2.8
S.D. 7.73 0.93 7.33 7.89 2.39 7.56 2.64 0.15
No. 3 3 3 3 3 3 3 3
Out 0 0 0 0 0 0 0 0
All Results
Median 22.7 2.8 10.6 15.0 6.9 18.8 7.0 2.8
Mean 25.4 3.0 13.2 17.7 8.4 21.8 8.5 2.9
S.D. 5.65 0.46 4.54 5.92 2.30 5.62 2.47 0.43
No. 23 23 25 25 26 26 26 26
Out 1 0 0 0 0 0 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Cortisol (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
55 55
45 45
No. of Laboratories
No. of Laboratories
35 35
25 25
15 15
5 5
4 4
3 3
2 2
1 1
<5 30 45 60 >85 <116 163 192 221 >268

Target Target
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<205 288 339 390 >473 <294 413 486 559 >678
Target Target
LEVEL 5 : 21-06 LEVEL 6 : 21-01
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<382 537 632 727 >882 <471 662 779 896 >1087
Target Target
Endocrine
Page 56
Cortisol (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
1046 760 31 352 505 195 597 210 35 J 01P 001
261 730 34 355 483 205 646 223 45 J 01W 001
10459 765 27 353 500 196 631 197 38 J 01W 001
1284 761 41 390 530 224 675 192 36 J 09Y 016
10608 I 11L 069 B
158 964 46 264 387 198 728 196 42 J 13P 098
2637 1042 48 442 727 220 729 231 49 J 13P 098
10101 J 13P 098
Median 765 39 355 505 204 660 208 44
Mean 828 38 362 525 206 666 210 42
S.D. 122.2 7.7 53.6 102.4 10.8 46.4 15.5 5.4
No. 7 7 7 7 8 8 8 8
Out 0 0 0 0 0 0 0 0
All Results
Median 798 42 359 509 207 652 206 42
Mean 826 42 371 523 211 675 211 43
S.D. 89.8 6.8 42.5 59.2 18.2 80.7 22.4 7.1
No. 116 116 120 115 123 122 124 124
Out 3 3 1 6 0 1 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
DHEA Sulphate (µmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
55 15
45 13
No. of Laboratories
No. of Laboratories
35 11
25 9
15 7
5 5
4 4
3 3
2 2
1 1
0.2 1.4 2.6 >4.6 <3.2 5.2 6.4 7.6 >9.6

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<7.5 9.7 11.0 12.3 >14.5 <10.4 13.4 15.2 17.0 >20.0
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 15
9 13
No. of Laboratories
No. of Laboratories
8 11
7 9
6 7
5 5
4 4
3 3
2 2
1 1
<13.4 17.2 19.6 22.0 >25.8 <16.2 20.8 23.7 26.5 >31.1
Median Median
Endocrine
Page 58
DHEA Sulphate (µmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
261 21.1 1.4 11.3 15.2 6.9 20.2 6.7 1.4 J 01W 001
158 23.3 1.4 8.3 12.7 7.2 21.4 5.3 1.1 J 20B 030
1046 23.9 1.1 10.7 14.8 6.5 19.6 6.9 1.2 J 20B 030
10459 23.0 1.1 10.9 15.2 6.0 19.1 5.9 1.4 J 20B 030
Median 23.1 1.2 10.8 15.0 6.7 19.9 6.3 1.3
Mean 22.8 1.2 10.3 14.5 6.7 20.1 6.2 1.3
S.D. 1.21 0.17 1.36 1.20 0.52 0.99 0.74 0.15
No. 4 4 4 4 4 4 4 4
Out 0 0 0 0 0 0 0 0
All Results
Median 23.7 1.4 11.0 15.2 6.4 19.6 6.5 1.4
Mean 24.1 1.4 11.2 15.7 6.6 19.9 6.6 1.4
S.D. 1.86 0.34 1.35 1.79 0.97 1.94 1.00 0.36
No. 58 61 66 66 68 67 68 68
Out 4 1 1 1 1 2 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
17-Hydroxyprogesterone (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
55 30
45 25
No. of Laboratories
No. of Laboratories
35 20
25 15
15 10
5 5
4 4
3 3
2 2
1 1
0.8 2.8 >6.1 <2.6 5.9 7.9 9.9 >13.2

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<6.6 11.2 14.0 16.8 >21.4 <9.8 16.6 20.7 24.8 >31.6
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<12.7 21.5 26.9 32.3 >41.1 <15.0 25.4 31.7 38.0 >48.4
Median Median
Endocrine
Page 60
17-Hydroxyprogesterone (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
2438 29.6 0.7 12.8 18.1 7.6 24.9 7.7 0.7 M 22D 000
10459 36.1 0.8 16.2 19.6 8.1 28.0 8.3 0.9 M 22D 000
Median 32.8 0.8 14.5 18.9 7.9 26.5 8.0 0.8
Mean 32.8 0.8 14.5 18.9 7.9 26.5 8.0 0.8
S.D. 4.60 0.07 2.40 1.06 0.35 2.19 0.42 0.14
No. 2 2 2 2 2 2 2 2
Out 0 0 0 0 0 0 0 0
All Results
Median 31.7 0.8 14.0 20.7 7.9 26.9 7.9 0.9
Mean 31.7 0.8 13.6 19.7 7.8 26.2 7.6 0.9
S.D. 4.58 0.15 2.07 3.51 0.86 3.21 0.88 0.23
No. 27 27 28 28 28 28 29 29
Out 2 2 1 1 1 1 1 1

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Oestradiol (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 60
25 50
No. of Laboratories
No. of Laboratories
20 40
15 30
10 20
5 10
4 8
3 6
2 4
1 2
<27 68 93 118 >159 <74 164 218 272 >362

Target Target
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<117 256 342 428 >567 <159 350 467 584 >775
Target Target
LEVEL 5 : 21-06 LEVEL 6 : 21-01
55 55
45 45
No. of Laboratories
No. of Laboratories
35 35
25 25
15 15
5 5
4 4
3 3
2 2
1 1
<202 444 592 740 >982 <244 538 717 896 >1190
Target Target
Endocrine
Page 62
Oestradiol (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 578 108 330 412 233 509 234 106 J 01P 001
2143 J 01P 001
261 614 88 363 447 292 540 246 96 J 01W 001
10459 533 58 380 410 245 483 239 102 J 01W 001
452 471 156 326 385 266 409 255 160 J 09Y 016
1284 435 92 297 354 228 402 284 181 J 09Y 016
40 690 < 100 305 396 234 550 209 < 100 J 13P 098 C
158 695 97 265 373 241 588 246 102 J 13P 098 C
1248 778 130 322 405 238 580 217 < 100 J 13P 098 C
10101 766 132 249 358 234 611 245 101 J 13P 098 C
22F - Sample Preparation Direct Injection
2438 813 102 392 543 251 609 238 100 T 22F 000
Median 652 100 324 400 240 545 242 102
Mean 637 106 323 408 246 528 241 115
S.D. 132.0 27.3 46.6 54.9 19.5 76.6 20.5 30.0
No. 10 10 10 10 10 10 10 10
Out 0 0 0 0 0 0 0 0
All Results
Median 628 108 360 465 254 554 248 106
Mean 615 109 358 451 252 540 250 110
S.D. 84.7 27.7 35.3 51.6 28.8 66.6 27.1 26.0
No. 180 181 185 187 186 187 188 188
Out 3 2 4 2 3 2 4 4

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Progesterone (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
80 55
65 45
No. of Laboratories
No. of Laboratories
50 35
35 25
20 15
5 5
4 4
3 3
2 2
1 1
<6 8 10 12 >14 <16 23 27 31 >38

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<24 34 40 46 >56 <32 45 53 61 >74

Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<41 58 68 78 >95 <50 70 82 94 >114

Median Median
Endocrine
Page 64
Progesterone (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
729 81 9 38 53 24 61 25 9 J 01P 001
2143 J 01P 001
261 73 8 36 51 23 62 21 8 J 01W 001
10459 78 8 38 53 24 62 22 8 J 01W 001
452 82 7 43 57 20 67 18 5 J 09Y 016
1284 86 5 44 57 23 67 23 7 J 09Y 016
40 61 11 35 42 27 53 28 11 J 13P 098
158 60 12 31 36 28 52 25 10 J 13P 098
1248 59 12 34 45 30 58 26 12 J 13P 098
10101 60 12 29 35 25 48 27 11 J 13P 098
2438 99 9 47 64 27 75 29 10 T 22D 000
Median 76 9 37 52 24 62 25 10
Mean 74 9 38 49 25 60 24 9
S.D. 13.7 2.4 5.8 9.5 2.9 8.1 3.4 2.1
No. 10 10 10 10 10 10 10 10
Out 0 0 0 0 0 0 0 0
All Results
Median 82 10 40 53 27 68 27 10
Mean 83 10 41 55 27 69 27 10
S.D. 13.2 1.8 5.4 7.6 3.7 10.1 3.4 1.9
No. 181 179 190 189 189 189 192 192
Out 2 3 1 2 0 0 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Testosterone (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
60 30
50 25
No. of Laboratories
No. of Laboratories
40 20
30 15
20 10
10 5
8 4
6 3
4 2
2 1
0.2 0.6 1.0 >1.7 <2.2 3.1 3.7 4.3 >5.2

Target Target
LEVEL 3 : 21-03 LEVEL 4 : 21-04
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<4.1 5.8 6.8 7.8 >9.5 <6.0 8.4 9.9 11.4 >13.8
Target Target
LEVEL 5 : 21-06 LEVEL 6 : 21-01
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<7.9 11.1 13.0 14.9 >18.1 <9.8 13.8 16.2 18.6 >22.6
Target Target
Endocrine
Page 66
Testosterone (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
2143 17.2 0.5 7.1 10.4 4.1 14.7 4.2 0.5 J 01P 001
261 16.5 0.5 7.7 11.1 4.1 14.5 4.2 0.5 J 01W 001
10608 18.0 0.5 7.7 11.0 4.5 15.1 4.4 0.5 J 01W 001
158 17.4 0.1 6.2 8.7 3.8 12.7 4.0 0.1 I 11L 069
2438 16.3 0.5 7.9 11.0 4.0 13.7 4.3 0.6 M 22D 000
10459 16.0 0.6 7.0 10.0 3.7 12.0 3.3 0.5 M 22D 000
Median 16.9 0.5 7.4 10.7 4.1 14.1 4.2 0.5
Mean 16.9 0.5 7.3 10.4 4.0 13.8 4.1 0.5
S.D. 0.76 0.18 0.63 0.92 0.28 1.22 0.40 0.18
No. 6 6 6 6 6 6 6 6
Out 0 0 0 0 0 0 0 0
All Results
Median 16.0 0.3 7.2 10.3 3.8 13.2 3.8 0.3
Mean 15.7 0.3 7.1 10.2 3.8 13.1 3.8 0.3
S.D. 1.45 0.19 0.59 0.84 0.35 1.08 0.37 0.19
No. 104 100 107 109 111 109 111 108
Out 4 1 4 2 2 4 1 1

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Dihydrotestosterone (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
0.04 0.14 0.24 >0.40 <0.14 0.30 0.40 0.50 >0.66

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<0.40 0.57 0.67 0.76 >0.93 <0.58 0.82 0.97 1.11 >1.35
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<0.71 1.00 1.18 1.36 >1.65 <0.85 1.19 1.40 1.61 >1.95
Median Median
Endocrine
Page 68
Dihydrotestosterone (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
2438 1.33 0.07 0.66 1.01 0.37 1.18 0.39 0.09 T 22D 000
Median 1.33 0.07 0.66 1.01 0.37 1.18 0.39 0.09
Mean 1.33 0.07 0.66 1.01 0.37 1.18 0.39 0.09
S.D. 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
All Results
Median 1.40 0.12 0.67 0.97 0.42 1.18 0.39 0.15
Mean 1.54 0.16 0.69 0.95 0.45 1.29 0.46 0.20
S.D. 0.570 0.086 0.121 0.089 0.163 0.345 0.146 0.155
No. 9 9 10 10 12 12 10 10
Out 0 0 0 0 1 1 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
11-Deoxycortisol (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
0.07 0.67 1.27 >2.25 <4.87 8.24 10.30 12.36 >15.73

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<9.33 15.80 19.75 23.70 >30.17 <13.86 23.46 29.33 35.20 >44.80
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<18.13 30.68 38.35 46.03 >58.58 <21.17 35.83 44.78 53.74 >68.40
Median Median
Endocrine
Page 70
11-Deoxycortisol (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
Median 47.20 0.50 21.21 31.92 10.70 39.70 11.96 0.68
Mean 47.20 0.50 21.21 31.92 10.70 39.70 11.96 0.68
S.D. 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
All Results
Median 44.78 0.63 19.75 29.33 10.45 38.35 10.30 0.70
Mean 45.84 0.54 20.19 29.83 10.39 38.48 10.57 0.78
S.D. 3.801 0.226 0.989 1.616 0.620 2.331 0.885 0.239
No. 8 6 9 9 8 8 9 7
Out 0 0 0 0 0 0 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Vitamin D (Total) (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
12 21 30 >45 <13 28 37 46 >61

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<33 48 57 66 >81 <52 73 86 99 >120

Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<66 93 110 126 >153 <79 111 131 151 >183

Median Median
Endocrine
Page 72
Vitamin D (Total) (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
10459 163 14 69 99 41 129 40 14 J 01W 001 M
Median 163 14 69 99 41 129 40 14
Mean 163 14 69 99 41 129 40 14
S.D. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
Median 163 14 69 99 41 129 40 14
Mean 163 14 69 99 41 129 40 14
S.D. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0

Median 163 14 69 99 41 129 40 14
Mean 163 14 69 99 41 129 40 14
S.D. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
All Results
Median 131 21 57 86 38 110 37 21
Mean 134 28 62 86 38 110 39 26
S.D. 24.2 16.5 14.5 14.5 8.8 14.9 9.4 13.8
No. 19 19 18 18 22 22 21 21
Out 0 0 0 0 0 0 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Vitamin D3 (25-hydroxy Vitamin D3) (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
13 22 31 >46 <27 42 51 60 >75

Target Target
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<48 68 80 92 >112 <66 93 109 125 >152

Target Target
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<83 117 138 159 >193 <101 142 167 192 >233
Target Target
Endocrine
Page 74
Vitamin D3 (25-hydroxy Vitamin D3) (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
1046 163 16 60 88 38 117 36 14 J 01P 001 M
2143 156 13 63 94 36 129 173 113 J 01P 001 M
10608 J 01P 001 M
Median 160 14 62 91 37 123 104 64
Mean 160 14 62 91 37 123 104 64
S.D. 4.9 2.1 2.1 4.2 1.4 8.5 96.9 70.0
No. 2 2 2 2 2 2 2 2
Out 0 0 0 0 0 0 0 0
Median 154 15 63 91 38 122 39 15
Mean 153 16 63 92 38 122 38 15
S.D. 15.3 2.7 3.0 4.8 1.9 5.4 2.0 1.7
No. 17 17 19 19 19 19 18 18
Out 0 0 0 0 0 0 1 1

158 134 26 77 110 53 124 59 34 J 13P 098 M
10101 153 34 78 103 43 134 67 26 J 13P 098 M
Median 144 30 78 106 48 129 63 30
Mean 144 30 78 106 48 129 63 30
S.D. 13.4 5.7 0.7 4.9 7.1 7.1 5.7 5.7
No. 2 2 2 2 2 2 2 2
Out 0 0 0 0 0 0 0 0
Median 142 24 79 106 56 133 64 30
Mean 143 25 81 106 56 132 64 31
S.D. 9.9 6.5 6.0 4.2 11.0 5.6 5.1 6.7
No. 4 4 4 4 4 4 4 4
Out 0 0 0 0 0 0 0 0

40 110 17 57 76 33 95 34 21 J 99B 135 D
261 126 18 59 80 37 106 31 16 J 99B 135 C
2637 111 16 61 81 34 96 38 21 J 99B 135

ABN 32 003 520 072
Page 75
Vitamin D3 (25-hydroxy Vitamin D3) (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08 (Continued)
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
Median 111 17 59 80 34 96 34 21
Mean 116 17 59 79 35 99 34 19
S.D. 9.0 1.0 2.0 2.6 2.1 6.1 3.5 2.9
No. 3 3 3 3 3 3 3 3
Out 0 0 0 0 0 0 0 0
Median 113 18 55 76 36 98 35 20
Mean 115 18 55 76 36 99 35 20
S.D. 8.2 1.7 3.7 3.9 2.3 4.6 2.7 2.2
No. 17 17 16 16 16 16 17 17
Out 0 0 0 0 0 0 0 0

Median 144 18 62 91 38 120 48 24
Mean 141 21 67 92 41 118 62 34
S.D. 23.9 7.0 9.9 13.1 8.3 18.6 46.9 32.6
No. 8 8 8 8 8 8 8 8
Out 0 0 0 0 0 0 0 0
All Results
Median 134 18 62 90 38 118 38 19
Mean 139 19 64 89 40 115 41 19
S.D. 24.1 5.6 12.4 14.5 8.0 15.4 9.8 4.9
No. 66 65 67 67 67 68 66 64
Out 0 1 0 0 2 1 1 3

ABN 32 003 520 072
Page 76
Active B12 (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 LEVEL 2 LEVEL 3
Specimen 21-02 Specimen 21-08 Specimen 21-05 Specimen 21-07 Specimen 21-03
Expected Quant Expected Quant Expected Quant Expected Quant Expected Quant
70 70 70
60 60 60
No. of Laboratories
50 50 50
40 40 40
30 30 30
20 20 20
10 10 10
0 0 0
Quant High Quant High Quant High Quant High Quant High
LEVEL 4 LEVEL 5 LEVEL 6
Specimen 21-04 Specimen 21-06 Specimen 21-01
Expected Quant Expected Quant Expected Quant
70 60 45
60 40
50
No. of Laboratories
35
50
40 30
40 25
30
30 20
20 15
20
10
10 10
5
0 0 0
Quant High Quant High Quant High
Group Results All Lab Results

Page 77
Active B12 (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Specimen Number Total
Lab No.1 2 3 4 5 6 7 8 Method Quant High
All results for Method Code # ### ### # :
40 High Quant D 01P 001 1 1
158 Quant Quant Quant Quant Quant Quant Quant Quant D 13P 098 8 0
261 High Quant Quant Quant Quant Quant Quant Quant D 01W 001 7 1
729 High Quant Quant Quant Quant Quant Quant Quant D 01P 001 7 1
10101 Quant Quant Quant Quant Quant Quant Quant Quant D 13P 098 8 0
10459 Quant Quant Quant Quant Quant Quant Quant Quant D 01W 001 8 0
- Summary -
Quant 3 6 5 5 5 5 5 5
High 3
Total 6 6 5 5 5 5 5 5

- Summary -
Quant 3 6 5 5 5 5 5 5
High 3
Total 6 6 5 5 5 5 5 5
All results
Quant 18 62 62 61 63 56 62 61
High 45 1 6
Total 63 62 62 62 63 62 62 61
Expec Quant Quant Quant Quant Quant Quant Quant Quant 8 0
Results
CPEN00550400020024-100SUP02
Active B12 Quant (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
3 8 >16 <18 26 31 36 >44

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
15 15
13 13
No. of Laboratories
No. of Laboratories
11 11
9 9
7 7
5 5
4 4
3 3
2 2
1 1
<37 52 61 70 >85 <53 75 88 101 >123

Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
15 10
13 9
No. of Laboratories
No. of Laboratories
11 8
9 7
7 6
5 5
4 4
3 3
2 2
1 1
<69 96 114 131 >158 <73 102 120 138 >167

Median Median
Endocrine
Page 79
Active B12 Quant (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
40 High <5 D 01P 001
729 High <5 65 94 34 125 35 <5 D 01P 001
261 High <1 67 92 34 109 33 1 D 01W 001
10459 127 1 62 84 33 122 29 <5 D 01W 001
158 100 2 23 38 18 98 17 2 D 13P 098
10101 97 1 23 38 18 106 18 1 D 13P 098
Median Quant 100 1 62 84 33 109 29 1
Mean High 108 1 48 69 27 112 26 1
S.D. 16.5 0.6 22.9 28.7 8.6 11.3 8.4 0.6
No. Total 3 3 5 5 5 5 5 3
Out Out 0 0 0 0 0 0 0 0
All Results
Median Quant 120 3 61 88 32 114 31 2
Mean High 116 3 59 85 32 113 32 2
S.D. 23.7 1.6 9.7 16.1 2.3 11.9 2.5 1.4
No. Total 23 24 62 63 59 61 59 24
Out Out 1 0 2 0 8 1 7 0
Expec Expec 120 3 61 89 32 114 31 3
Results Results
* Results > 3 standard deviations from the Group Mean. Results outside the analytical performance specifications. Qualitative expected results.

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Parathyroid Hormone (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
55 30
45 25
No. of Laboratories
No. of Laboratories
35 20
25 15
15 10
5 5
4 4
3 3
2 2
1 1
0.9 1.9 2.9 >4.5 <3.0 4.6 5.6 6.6 >8.2

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
15 15
13 13
No. of Laboratories
No. of Laboratories
11 11
9 9
7 7
5 5
4 4
3 3
2 2
1 1
<23.7 30.5 34.7 38.9 >45.7 <42.3 54.5 61.9 69.3 >81.5
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 15
9 13
No. of Laboratories
No. of Laboratories
8 11
7 9
6 7
5 5
4 4
3 3
2 2
1 1
<62.2 80.1 91.0 101.9 >119.8 <76.8 98.8 112.3 125.8 >147.8
Median Median
Endocrine
Page 81
Parathyroid Hormone (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
2143 115.5 2.8 46.2 80.5 8.7 117.5 8.7 2.9 D 01P 001 I
Median 115.5 2.8 46.2 80.5 8.7 117.5 8.7 2.9
Mean 115.5 2.8 46.2 80.5 8.7 117.5 8.7 2.9
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
Median 142.4 2.9 46.8 82.0 8.3 117.6 8.6 2.9
Mean 139.2 2.9 46.9 81.1 8.4 117.7 8.4 2.9
S.D. 14.39 0.12 1.88 3.85 0.72 7.06 0.49 0.21
No. 15 15 14 15 15 15 16 16
Out 0 0 2 1 1 1 0 0

261 150.4 2.9 45.1 80.2 7.9 118.0 8.0 2.8 D 01W 001 I
Median 150.4 2.9 45.1 80.2 7.9 118.0 8.0 2.8
Mean 150.4 2.9 45.1 80.2 7.9 118.0 8.0 2.8
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
Median 145.6 2.8 44.1 79.1 7.8 114.0 8.0 2.8
Mean 144.5 2.7 43.7 78.9 7.9 113.9 7.8 2.7
S.D. 9.78 0.12 1.56 2.43 0.32 4.18 0.36 0.12
No. 15 14 15 15 15 15 15 15
Out 0 1 0 0 0 0 0 0

1284 132.5 2.0 35.8 66.3 6.8 104.3 5.0 1.6 D 09Y 016 I
Median 132.5 2.0 35.8 66.3 6.8 104.3 5.0 1.6
Mean 132.5 2.0 35.8 66.3 6.8 104.3 5.0 1.6
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
Median 109.9 1.9 34.8 61.1 5.9 92.0 5.6 1.9
Mean 109.8 1.9 34.8 62.4 5.9 91.7 5.6 1.9
S.D. 11.58 0.13 1.50 3.13 0.34 5.77 0.29 0.13
No. 13 13 13 13 13 13 13 13
Out 0 0 0 0 0 0 0 0

40 128.0 1.8 35.2 66.5 6.0 99.5 5.4 1.8 D 13P 098 I

ABN 32 003 520 072
Page 82
Parathyroid Hormone (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08 (Continued)
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
158 128.4 1.9 35.2 59.9 5.2 87.7 5.6 1.8 D 13P 098 A
2637 133.8 2.0 36.0 63.1 5.5 93.8 5.2 1.8 D 13P 098 I
Median 128.4 1.9 35.2 63.1 5.5 93.8 5.4 1.8
Mean 130.1 1.9 35.5 63.2 5.6 93.7 5.4 1.8
S.D. 3.24 0.10 0.46 3.30 0.40 5.90 0.20 0.00
No. 3 3 3 3 3 3 3 3
Out 0 0 0 0 0 0 0 0
Median 128.2 1.8 35.6 64.8 5.6 96.9 5.4 1.8
Mean 128.2 1.8 35.7 65.5 5.6 97.0 5.4 1.7
S.D. 8.23 0.36 2.88 5.50 0.34 5.01 0.27 0.31
No. 8 8 8 8 8 8 7 7
Out 0 0 0 0 0 0 0 0
58A - Beckman Coulter Access/Access 2

2368 115.0 1.9 33.2 59.2 5.7 89.4 D 58A 016 I
Median 115.0 1.9 33.2 59.2 5.7 89.4
Mean 115.0 1.9 33.2 59.2 5.7 89.4
S.D. 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1
Out 0 0 0 0 0 0
58A - Beckman Coulter Access/Access 2
Median 112.8 2.0 33.2 64.0 6.0 93.0 6.0 2.0
Mean 112.1 2.0 34.1 62.5 5.9 93.3 5.9 2.0
S.D. 7.34 0.08 3.14 5.01 0.38 3.71 0.11 0.00
No. 6 6 5 5 5 5 5 5
Out 0 0 0 0 0 0 0 0

Median 128.4 2.0 35.8 66.3 6.0 99.5 5.5 1.8
Mean 129.1 2.2 38.1 68.0 6.5 101.5 6.3 2.1
S.D. 12.06 0.46 5.25 8.92 1.32 12.49 1.60 0.57
No. 7 7 7 7 7 7 6 6
Out 0 0 0 0 0 0 0 0
All Results
Median 112.3 1.9 34.7 61.9 5.7 91.0 5.4 1.9
Mean 114.7 2.0 35.1 63.5 6.0 91.8 6.0 2.1
S.D. 24.07 0.55 7.48 13.08 1.44 20.23 1.48 0.55
No. 115 115 114 114 112 113 114 114
Out 0 0 1 1 3 2 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Parathyroid Hormone (Stat Assay) (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
15 30
13 25
No. of Laboratories
No. of Laboratories
11 20
9 15
7 10
5 5
4 4
3 3
2 2
1 1
0.6 1.6 2.6 >4.2 <2.2 3.8 4.8 5.8 >7.4

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<19.4 24.9 28.3 31.8 >37.3 <35.8 46.1 52.3 58.6 >68.9
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
15 10
13 9
No. of Laboratories
No. of Laboratories
11 8
9 7
7 6
5 5
4 4
3 3
2 2
1 1
<51.2 65.9 74.9 83.9 >98.6 <66.0 84.9 96.5 108.1 >127.0
Median Median
Endocrine
Page 84
Parathyroid Hormone (Stat Assay) (pmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
10459 101.6 2.6 38.8 66.5 5.7 66.0 7.4 2.6 D 01W 001 I
Median 101.6 2.6 38.8 66.5 5.7 66.0 7.4 2.6
Mean 101.6 2.6 38.8 66.5 5.7 66.0 7.4 2.6
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
Median 101.6 2.6 38.8 66.5 5.7 66.0 7.4 2.6
Mean 101.6 2.6 38.8 66.5 5.7 66.0 7.4 2.6
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0

Median 101.6 2.6 38.8 66.5 5.7 66.0 7.4 2.6
Mean 101.6 2.6 38.8 66.5 5.7 66.0 7.4 2.6
S.D. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
All Results
Median 96.5 1.6 28.3 52.3 4.8 74.9 4.7 1.7
Mean 105.4 1.9 33.1 59.3 5.6 85.0 6.0 2.1
S.D. 20.79 0.57 8.68 13.63 1.63 19.42 1.76 0.67
No. 27 27 27 27 28 28 24 24
Out 0 0 1 1 1 1 0 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Direct Renin (uIU/mL) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 15
25 13
No. of Laboratories
No. of Laboratories
20 11
15 9
10 7
5 5
4 4
3 3
2 2
1 1
<16 53 76 99 >136 <12 41 58 75 >104

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<9 30 42 55 >76 <6 19 27 35 >48

Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
7 13 19 >29 1 7 >17
Median Median
Endocrine
Page 86
Direct Renin (uIU/mL) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
261 < 1 73 38 24 55 15 54 79 D 99B 135
10459 1 87 58 33 65 14 66 74 D 99B 135
Median 1 80 48 28 60 14 60 76
Mean 1 80 48 28 60 14 60 76
S.D. 0.0 9.9 14.1 6.4 7.1 0.7 8.5 3.5
No. 1 2 2 2 2 2 2 2
Out 0 0 0 0 0 0 0 0
All Results
Median 1 76 42 27 57 13 58 76
Mean 1 76 42 27 56 13 59 78
S.D. 0.4 6.5 3.3 2.8 8.8 2.0 4.6 5.9
No. 8 20 21 21 22 23 20 19
Out 0 0 1 1 1 0 1 1

ABN 32 003 520 072
CPEN00550400020024-100SUP02
s-BetaCTX (ng/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<23 39 49 59 >75 <161 197 219 241 >277

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<291 356 395 434 >499 <421 515 572 629 >723
Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<545 666 740 814 >935 <685 837 930 1023 >1175
Median Median
Endocrine
Page 88
s-BetaCTX (ng/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
10459 881 26 402 594 200 741 188 < 10 I 11L 069
Median 881 26 402 594 200 741 188 9
Mean 881 26 402 594 200 741 188 9
S.D. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
All Results
Median 930 45 395 572 218 740 220 50
Mean 935 42 392 568 214 741 219 47
S.D. 47.3 15.1 24.2 32.8 11.6 34.9 15.8 17.7
No. 21 22 22 22 23 24 24 25
Out 1 0 2 2 2 1 1 0

ABN 32 003 520 072
CPEN00550400020024-100SUP02
Procollagen Type 1 N-Terminal Propeptide (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
LEVEL 1 : 21-02 & 21-08 LEVEL 2 : 21-05 & 21-07
30 30
25 25
No. of Laboratories
No. of Laboratories
20 20
15 15
10 10
5 5
4 4
3 3
2 2
1 1
<2 10 15 20 >28 <18 26 31 36 >44

Median Median
LEVEL 3 : 21-03 LEVEL 4 : 21-04
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<37 45 50 55 >63 <51 63 70 76 >88

Median Median
LEVEL 5 : 21-06 LEVEL 6 : 21-01
10 10
9 9
No. of Laboratories
No. of Laboratories
8 8
7 7
6 6
5 5
4 4
3 3
2 2
1 1
<64 78 87 96 >110 <80 97 108 119 >136

Median Median
Endocrine
Page 90
Procollagen Type 1 N-Terminal Propeptide (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08
Lab 21-01 21-02 21-03 21-04 21-05 21-06 21-07 21-08
10459 102 15 53 70 39 111 33 17 I 11L 069
Median 102 15 53 70 39 111 33 17
Mean 102 15 53 70 39 111 33 17
S.D. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
No. 1 1 1 1 1 1 1 1
Out 0 0 0 0 0 0 0 0
All Results
Median 108 15 50 70 31 87 31 15
Mean 109 15 50 69 30 83 32 15
S.D. 6.4 1.1 3.6 4.6 3.6 15.0 1.4 1.0
No. 22 22 23 23 25 27 25 25
Out 1 1 1 1 2 0 2 2

ABN 32 003 520 072
CPEN00550400020024-100SUP02
This is the last page of report.
Endocrine

Sup Report

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Sup Report

Uploaded by

Copyright:

Available Formats

Participant Number 20024

Suite 201, 8 Herbert

2021 Endocrine Program Update

INSULIN IN 2021 ENDOCRINE MATERIAL

Alpha-fetoprotein (kIU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

1 3 5 >8 <14 18 21 24 >28

<26 33 38 42 >49 <37 48 54 60 >71

<49 62 71 80 >93 <60 77 88 99 >116

Alpha-fetoprotein (kIU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

CA-125 (kU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

8 14 20 >30 <23 33 39 45 >55

<41 53 60 67 >79 <55 71 81 91 >107

<70 90 102 115 >135 <83 106 121 136 >159

CA-125 (kU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

Ferritin (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

<6 13 17 21 >28 <122 172 202 233 >283

Ferritin (µg/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

Folate (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Folate (nmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

Growth Hormone (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

0.4 1.4 >3.0 <1.6 3.2 4.2 5.2 >6.8

Growth Hormone (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

0.0 1.0 2.0 >3.6 <53.7 65.7 73.0 80.3 >92.3

01W - Abbott Alinity i

09Y - Beckman Coulter UniCel DxI 600/800

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

13P - Siemens Healthcare Diagnostics ADVIA Centaur/XP/XPT

20B - Siemens Healthcare Diagnostics Immulite 2000/2000 XPi

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

Homocysteine (µmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Homocysteine (µmol/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

Insulin (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

0.5 1.1 >2.1 <0.7 1.7 2.3 2.9 >3.9

Insulin (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

Luteinising Hormone (IU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

0.9 2.4 3.9 >6.4 <12.7 17.9 21.0 24.1 >29.3

Luteinising Hormone (IU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

Prolactin (mIU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

Prolactin (mIU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

9 15 21 >31 <4 14 20 26 >36

<7 17 23 29 >39 <11 21 27 33 >43

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

TSH (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

0.02 0.12 >0.28 <2.11 3.58 4.47 5.36 >6.83

TSH (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08

01W - Abbott Alinity i

13P - Siemens Healthcare Diagnostics ADVIA Centaur/XP/XPT

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology

TSH (mU/L) : Supervisor20024 Report for Cycle 21 - to Specimen 21-08 (Continued)

WESTERN AUSTRALIA GROUP Supervisor

©RCPA Quality Assurance Programs Pty. Limited RCPAQAP Chemical Pathology